Alternative treatment protocols in giardiasis: a pilot study

Scandinavian Journal of Infectious Diseases
B U BulutD Aysev

Abstract

The aim of the study was to test new treatment protocols for giardiasis, which are less toxic, cheaper, and easier to use than the conventional treatment. 48 children who had been diagnosed as having giardiasis in a health-screening program involving 2 schools, were randomized to receive four different treatment protocols. The children were split into 4 treatment groups: I, mebendazole 100 mg t.i.d. for 1 day; II, mebendazole 100 mg t.i.d. for 7 days; III, metronidazole 15 mg/kg as one dose for 7 days; and IV, ornidazole 40 mg/kg as a single dose. The results were evaluated by microscopic examination of stools. The responses to the treatments revealed that the effectiveness of ornidazole was 100%, metronidazole 92.9%, mebendazole for 7 days 58.3%, and mebendazole for 1 day 41.7%. Minor side-effects were seen in only 3 children receiving ornidazole: 1 had urticaria, while the other 2 suffered from vertigo and nausea. The results of this study show that ornidazole as a single dose can be used as an alternative protocol for treating giardiasis. Further studies should be done to determine the safest effective total single dose.

References

Nov 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B OrenR Raz
Sep 1, 1990·Transactions of the Royal Society of Tropical Medicine and Hygiene·N S al-Waili
Jan 1, 1988·Transactions of the Royal Society of Tropical Medicine and Hygiene·N S al-WailiK Y Saloom
Nov 1, 1985·The Journal of Antimicrobial Chemotherapy·P F BorehamR W Shepherd
Jan 1, 1985·Transactions of the Royal Society of Tropical Medicine and Hygiene·R H GilmanM U Khan
May 1, 1993·Parasitology Today·J A Upcroft, P Upcroft

❮ Previous
Next ❯

Citations

Jan 21, 2006·Parasitology Research·Martha Ponce-MacotelaMario Noé Martínez-Gordillo
Feb 7, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·R CañeteS Cimerman
Feb 9, 2012·Parasitology·Yadira Rufino-GonzálezMario N Martínez-Gordillo
Jan 9, 2001·Clinical Microbiology Reviews·T B Gardner, D R Hill
May 21, 2010·PLoS Neglected Tropical Diseases·Shahram Solaymani-MohammadiSteven M Singer
Mar 15, 2014·PLoS Neglected Tropical Diseases·Vinay PasupuletiAdrian V Hernandez
Aug 27, 2009·Biologics : Targets & Therapy·Haendel G N O BusattiMaria A Gomes
Jan 5, 2002·Expert Opinion on Investigational Drugs·T G Mank, J O Zaat
Oct 27, 1998·Mayo Clinic Proceedings·A E Denktas, P L Elkin
Aug 19, 2007·Expert Opinion on Pharmacotherapy·Angel A Escobedo, Sergio Cimerman
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Carlos E GranadosClaudia P Criollo
Feb 24, 2001·The American Journal of Gastroenterology·J K TriantafillidisI Hereti
Jul 20, 2007·The Cochrane Database of Systematic Reviews·J O M ZaatW J J Assendelft
Aug 11, 2020·Current Opinion in Infectious Diseases·Kristine Mørch, Kurt Hanevik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.